ZA857B - Inert matrix based on polycaprolactone for the oral administration of a drug,and method for the preparation of the galenic form comprising this matrix - Google Patents

Inert matrix based on polycaprolactone for the oral administration of a drug,and method for the preparation of the galenic form comprising this matrix

Info

Publication number
ZA857B
ZA857B ZA857A ZA857A ZA857B ZA 857 B ZA857 B ZA 857B ZA 857 A ZA857 A ZA 857A ZA 857 A ZA857 A ZA 857A ZA 857 B ZA857 B ZA 857B
Authority
ZA
South Africa
Prior art keywords
matrix
preparation
polycaprolactone
drug
oral administration
Prior art date
Application number
ZA857A
Other languages
English (en)
Inventor
Herve Grouiller
Fabien Christ
Original Assignee
Lhd Lab Hygiene Dietetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lhd Lab Hygiene Dietetique filed Critical Lhd Lab Hygiene Dietetique
Publication of ZA857B publication Critical patent/ZA857B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Preparations (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Materials For Medical Uses (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
ZA857A 1984-01-02 1985-01-02 Inert matrix based on polycaprolactone for the oral administration of a drug,and method for the preparation of the galenic form comprising this matrix ZA857B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8400015A FR2557459B1 (fr) 1984-01-02 1984-01-02 Matrice inerte a base de polycaprolactone pour administration orale d'un medicament, et procede de preparation de la forme galenique comprenant cette matrice

Publications (1)

Publication Number Publication Date
ZA857B true ZA857B (en) 1985-08-28

Family

ID=9299789

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA857A ZA857B (en) 1984-01-02 1985-01-02 Inert matrix based on polycaprolactone for the oral administration of a drug,and method for the preparation of the galenic form comprising this matrix

Country Status (23)

Country Link
US (1) US4629624A (cs)
EP (1) EP0147335B1 (cs)
JP (1) JPS60185729A (cs)
KR (1) KR850005271A (cs)
AT (1) ATE33553T1 (cs)
AU (1) AU574024B2 (cs)
CA (1) CA1238856A (cs)
CS (1) CS247190B2 (cs)
DD (1) DD235829A5 (cs)
DE (1) DE3470459D1 (cs)
DK (1) DK616084A (cs)
ES (1) ES8605682A1 (cs)
FI (1) FI79942C (cs)
FR (1) FR2557459B1 (cs)
GR (1) GR82607B (cs)
HU (1) HU193731B (cs)
IL (1) IL73957A (cs)
NO (1) NO160412C (cs)
OA (1) OA08018A (cs)
PH (1) PH22167A (cs)
PT (1) PT79786B (cs)
YU (1) YU223884A (cs)
ZA (1) ZA857B (cs)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU86077A1 (fr) * 1985-09-18 1987-04-02 Pharlyse Sa Nouvelles formes galeniques du verapamil,leur fabrication et medicaments contenant ces nouvelles formes galeniques
DE3701625A1 (de) * 1987-01-21 1988-08-04 Boehringer Ingelheim Kg Perorale arzneimittelzubereitung mit verzoegerter wirkstofffreigabe
SE8701479L (sv) * 1987-04-09 1988-10-10 Carbomatrix Ab Metod foer inneslutning av biologiskt verksamma preparat samt anvaendning daerav
FR2627696B1 (fr) * 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
GB8805286D0 (en) * 1988-03-05 1988-04-07 Schering Agrochemicals Ltd Trypanocides
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
FR2791569B1 (fr) * 1999-03-31 2003-05-09 Pf Medicament Composition ou structure microporeuse expansee isotrope a dissolution rapide a usage pharmaceutique, veterinaire, dietetique, alimentaire ou cosmetique et son procede d'obtention
US6531158B1 (en) 2000-08-09 2003-03-11 Impax Laboratories, Inc. Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
US20060068015A1 (en) * 2003-10-10 2006-03-30 Per Holm Solid dosage form comprising a fibrate and a statin
US9173847B2 (en) * 2003-10-10 2015-11-03 Veloxis Pharmaceuticals A/S Tablet comprising a fibrate
KR20060085686A (ko) * 2003-10-10 2006-07-27 라이프사이클 파마 에이/에스 피브레이트를 포함하는 고형 제제
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
FR2912751B1 (fr) * 2007-02-16 2012-07-13 Arkema France Procede de preparation de polylactones et polylactames
FR2912752B1 (fr) * 2007-02-16 2012-10-05 Arkema France Procede de preparation d'un copolymere d'au moins un monomere cyclique
AU2013203747B2 (en) * 2008-09-18 2016-01-07 Purdue Pharma L.P. Pharmaceutical dosage forms comprising poly(e-caprolactone)
CA2737257C (en) * 2008-09-18 2016-11-15 Purdue Pharma L.P. Pharmaceutical dosage forms comprising poly(.epsilon.-caprolactone)
ES2603278T3 (es) * 2011-12-09 2017-02-24 Purdue Pharma Lp Formas farmacéuticas de dosificación que comprenden poli (epsilon-caprolactona) y óxido de polietileno

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1490855A (fr) * 1965-08-27 1967-08-04 Shell Int Research Procédé pour la fabrication d'articles en polyesters provenant de la polymérisation des lactones
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US3929937A (en) * 1972-07-28 1975-12-30 Union Carbide Corp Biodegradable shaped articles from a material comprising a particulate addition polymer in a matrix of a thermoplastic oxyalkanoyl polymer
US4095791A (en) * 1976-08-23 1978-06-20 Fairchild Camera And Instrument Corp. Cartridge programmable video game apparatus
FR2377431A1 (fr) * 1977-01-12 1978-08-11 Inst Sint Smol Procede de preparation de materiaux polymeres a pores ouverts
FR2397840B1 (cs) * 1977-07-22 1981-03-20 Cherqui Jean
US4148871A (en) * 1977-10-11 1979-04-10 Pitt Colin G Sustained subdermal delivery ofdrugs using poly(ε-caprolactone) and its copolymers

Also Published As

Publication number Publication date
YU223884A (en) 1987-10-31
NO845273L (no) 1985-07-03
IL73957A0 (en) 1985-03-31
FI845088L (fi) 1985-07-03
PT79786B (fr) 1986-10-28
CS247190B2 (en) 1986-12-18
EP0147335A3 (en) 1985-07-31
IL73957A (en) 1988-02-29
FI845088A0 (fi) 1984-12-21
DK616084A (da) 1985-07-03
PT79786A (fr) 1985-02-01
NO160412C (no) 1989-04-19
FR2557459B1 (fr) 1986-05-30
DD235829A5 (de) 1986-05-21
AU574024B2 (en) 1988-06-23
ATE33553T1 (de) 1988-05-15
OA08018A (fr) 1987-01-31
ES8605682A1 (es) 1986-04-01
DE3470459D1 (en) 1988-05-26
CA1238856A (en) 1988-07-05
KR850005271A (ko) 1985-08-24
AU3720984A (en) 1985-07-11
EP0147335A2 (fr) 1985-07-03
US4629624A (en) 1986-12-16
FI79942B (fi) 1989-12-29
JPS60185729A (ja) 1985-09-21
DK616084D0 (da) 1984-12-20
HU193731B (en) 1987-11-30
HUT37567A (en) 1986-01-23
FR2557459A1 (fr) 1985-07-05
FI79942C (fi) 1990-04-10
GR82607B (en) 1985-02-11
ES539187A0 (es) 1986-04-01
EP0147335B1 (fr) 1988-04-20
NO160412B (no) 1989-01-09
PH22167A (en) 1988-06-28

Similar Documents

Publication Publication Date Title
IL73957A (en) Inert matrix based on polycaprolactone for the oral administration of a drug and method for the preparation of the galenic form comprising this matrix
HUT49366A (en) Process for producing 2',3'-dideoxy-2',2'-difluoronucleosides and pharmaceutical compositions comprising same
CA2021767A1 (en) Method for preparing a pharmaceutical composition in the form of microparticles
IE882921L (en) "new pharmaceutical preparation and process for its preparation"
EP0248594A3 (en) Pharmacologically active 1,5-diaryl-3-substituted-pyrazopharmacologically active 1,5-diaryl-3-substituted-pyrazoles and method for synthesizing the same les and method for synthesizing the same
CA2017851A1 (en) Micronised biodegradable particles, process for preparing them and the use thereof
HUT50844A (en) Process for producing new 2'-halogen methylidene, 2'-ethenylidene and 2'-ethinyladenosine derivatives and pharmaceutical compositions comprising same as active ingredient
HUT54358A (en) Process for producing substituted 1,3,5-triazinetrione derivatives and medical compositions comprising such compounds as active ingredient
NZ223865A (en) 3'-azido or fluoro-2',3'-dideoxyribofuranosyl derivatives and pharmaceutical compositions therefrom
KR960016541B1 (en) 2,5,6,7-tetranor-4,8-inter-m-phenylene pgi2 derivatives, process for their preparation and use thereof
HUT54166A (en) Process for producing 1,1-dioxocefem-4-carbothiol acid derivatives and pharmaceutical compositions comprising same as active ingredient
HUT46364A (en) Process for producing 1,12-dihydroxy-1,6,12,13-tetraaza-dicyclodocosane-2,5,13,16-tetron and pharmaceutical compositions comprising this compound as active ingredient
EP0351876A3 (en) Composition for potentiating vaccination effect
HUT50340A (en) Process for producing 2'-, 12'- or 13'-substituted 3-(8'alpha-ergolinyl)-1,1-diethylurea and pharmaceutical compositions comprising the compounds
EP0348664A3 (en) Pharmaceutical compositions containing monoacetoacetins for treating tumours
HK2794A (en) 8a-acylaminoergoline, its preparation and pharmaceutical compositions containing it
EP0301239A3 (en) Use of gepirone for preparing pharmaceutical compositions for alleviation of panic disorders
PL277260A1 (en) Method of obtaining novel derivatives of tetrahydropyridine
Clarke Prolactin and calcium balance in the American eel, Anguilla rostrata.
Plotnikov Laws Governing Emission of Sound During Martensite Transformations in TiNi-Base Alloys
Greer Effects of NaCl on tobacco callus cultures
IL85920A0 (en) Substituted 1.3-dioxolane and 1,3-dioxane derivatives,their preparation and pharmaceutical compositions containing them
SG3294G (en) Pharmacologically active 1, 5-diaryl-3-substituted-pyrazoles and method for synthesizing the same
ZA873842B (en) Pharmacologically active 1,5-diarly-3-substituted-pyrazoles and method for synthesizing the same
IL86785A (en) 1,3-dioxane and tetrahydropyran derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same